Another Monster Biotech Deal: BMS Acquires Celgene for $74B
What a deal (https://news.bms.com/press-release/corporatefinan…).
Interesting that CVP aren't financial advisors for either side...
Thoughts?
What a deal (https://news.bms.com/press-release/corporatefinan…).
Interesting that CVP aren't financial advisors for either side...
Thoughts?
| +216 | UBS Accused of Favoring H-1B Workers While Cutting U.S.-Born Employees | 51 | 15h |
| +109 | IB Energy Drink Tier List / Ranking | 72 | 23h |
| +105 | ONLY THESE BANKS OR YOU STRUCK OUT | 33 | 14m |
| +91 | PJT M&A Group Selection 2026 | 14 | 18h |
| +51 | Feedback for internship first desk at IBD BB - personal fit, "don't be too confident" | 29 | 20h |
| +50 | Firm Thinks I'm Lying About Offer | 18 | 12h |
| +31 | Stay at Weak Dealflow Team or Lateral? | 7 | 22h |
| +30 | Does BofA still pay its associates rat pellets? | 15 | 20h |
| +27 | Rogo AI | 6 | 8h |
| +24 | Indiana University Fraternity Pipelines | 13 | 19h |
Career Resources
Doloremque veritatis neque ad accusantium dicta corporis. Ducimus et praesentium voluptatem ipsa modi ut. Repellat nulla molestiae vero molestiae et.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...